Apremilast approval expanded to include plaque psoriasis

The oral phosphodiesterase-4 inhibitor apremilast is now indicated for the treatment of moderate to severe plaque psoriasis. On Sept. 23, the manufacturer, Celgene, announced that the Food and Drug...

Field of Interest: Dermatology
Type: News Item

ACIP recommends PCV13 for all adults 65 and up

All adults who are 65 years or older should receive 13-valent pneumococcal conjugate vaccine (PCV13) routinely in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23), according to a...

Field of Interest: Geriatrics
Type: News Item

Births to unmarried women down since 2008

The nonmarital birth rate for women aged 15-44 years has declined 14% since peaking in 2007 and 2008, the National Center for Health Statistics reported. The rate was 44.8 births per 1,000 unmarried...

Field of Interest: Pulmonology
Type: News Item

FDA approves oritavancin for skin infections

The Food and Drug Administration has approved the injectable antibiotic oritavancin (Orbactiv) to treat adults with acute bacterial skin and skin structure infections that might be caused by...

Field of Interest: Dermatology
Type: News Item

OTC topical acne meds can cause severe reactions

The Food and Drug Administration says that some over-the-counter acne products can cause severe hypersensitivity or allergic reactions and is warning consumers to discontinue use immediately and seek...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness